Calabash Brothers: Wholly-owned subsidiary obtained registration certificate for electrolyte oral solution drug containing polyethylene glycol formula

The announcement of Huluo Wa stated that its wholly-owned subsidiary, Guangxi Weiwei, recently received the "Drug Registration Certificate" for the compound polyethylene glycol electrolyte oral solution approved and issued by the National Medical Products Administration. This drug is used for the treatment of chronic constipation and fecal impaction, and its approval is considered equivalent to passing the evaluation of generic drug quality and efficacy consistency. As of the date of the announcement, 21 domestic enterprises have been approved to market this drug. The company has cumulatively invested 762,100 yuan in research and development expenses for this product. There is uncertainty in the sales performance of the drug, so investors are reminded to pay attention to the risks.